Yingjie Yan Selected Research

Celecoxib (Celebrex)

5/2021

Interleukin-1β, interleukin-6, and interleukin-17A as indicators reflecting clinical response to celecoxib in ankylosing spondylitis patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yingjie Yan Research Topics

Disease

4	Goldenhar Syndrome (Hemifacial Microsomia) 01/2024 - 11/2022
2	Squamous Cell Carcinoma of Head and Neck 03/2023 - 01/2022
2	Inflammation (Inflammations) 01/2018 - 10/2017
1	Pain (Aches) 01/2024
1	Infections 03/2023
1	Congenital Abnormalities (Deformity) 03/2023
1	Suppuration 03/2023
1	Hemorrhage 11/2022
1	Tooth Injuries 11/2022
1	Bites and Stings (Sting) 11/2021
1	Ankylosing Spondylitis 05/2021
1	Pneumonia (Pneumonitis) 10/2017
1	Coccidiosis 02/2017

Drug/Important Bio-Agent (IBA)

2	Zinc Oxide FDA Link 01/2018 - 10/2017
1	Long Noncoding RNAIBA 03/2023
1	Biomarkers (Surrogate Marker)IBA 03/2023
1	paraform (paraformaldehyde)IBA 03/2023
1	SolutionsIBA 03/2023
1	InterferonsIBA 11/2021
1	Celecoxib (Celebrex)FDA Link 05/2021
1	Interleukin-6 (Interleukin 6)IBA 05/2021
1	CytokinesIBA 05/2021
1	Interleukin-17 (Interleukin 17)IBA 05/2021
1	Proteins (Proteins, Gene)FDA Link 01/2018
1	MicroRNAs (MicroRNA)IBA 01/2018
1	Interleukin-1 (Interleukin 1)IBA 01/2018
1	InflammasomesIBA 10/2017
1	nitromide (Unistat)IBA 02/2017
1	WastewaterIBA 02/2017

Therapy/Procedure

4	Distraction Osteogenesis 01/2024 - 11/2022
2	Osteotomy 03/2023 - 11/2022
1	Dental Occlusion 01/2024
1	Surgical Navigation Systems 03/2023
1	Immunotherapy 01/2022